[go: up one dir, main page]

BRPI0511615B8 - forma de administração oral compreendendo bactéria probiótica - Google Patents

forma de administração oral compreendendo bactéria probiótica

Info

Publication number
BRPI0511615B8
BRPI0511615B8 BRPI0511615A BRPI0511615A BRPI0511615B8 BR PI0511615 B8 BRPI0511615 B8 BR PI0511615B8 BR PI0511615 A BRPI0511615 A BR PI0511615A BR PI0511615 A BRPI0511615 A BR PI0511615A BR PI0511615 B8 BRPI0511615 B8 BR PI0511615B8
Authority
BR
Brazil
Prior art keywords
oral administration
administration form
probiotic bacteria
probiotic
bacteria
Prior art date
Application number
BRPI0511615A
Other languages
English (en)
Inventor
Manneck Iris
Rudolph Markus
Henke Stefan
Original Assignee
Merck Patent Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=34980007&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=BRPI0511615(B8) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Merck Patent Gmbh filed Critical Merck Patent Gmbh
Publication of BRPI0511615A publication Critical patent/BRPI0511615A/pt
Publication of BRPI0511615B1 publication Critical patent/BRPI0511615B1/pt
Publication of BRPI0511615B8 publication Critical patent/BRPI0511615B8/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2009—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2013—Organic compounds, e.g. phospholipids, fats
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/14—Prodigestives, e.g. acids, enzymes, appetite stimulants, antidyspeptics, tonics, antiflatulents

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Molecular Biology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Biophysics (AREA)
  • Inorganic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Nutrition Science (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Medicinal Preparation (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)

Abstract

forma de administração oral compreendendo bactéria probiótica. a invenção refere-se a uma forma de administração oral que compreende pelo menos uma espécie de microorganismos probióticos, em que eles próprios e/ou bactéria probiótica são fornecidos com um revestimento que compreende pelo menos dois éteres de celulose.
BRPI0511615A 2004-05-28 2005-05-04 forma de administração oral compreendendo bactéria probiótica BRPI0511615B8 (pt)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
DE102004026706A DE102004026706A1 (de) 2004-05-28 2004-05-28 Orale Darreichungsform enthaltend probiotische Bakterien
DE102004026706.5 2004-05-28
PCT/EP2005/004835 WO2005117921A1 (de) 2004-05-28 2005-05-04 Orale darreichungsform enthaltend probiotische bakterien

Publications (3)

Publication Number Publication Date
BRPI0511615A BRPI0511615A (pt) 2008-01-02
BRPI0511615B1 BRPI0511615B1 (pt) 2018-01-23
BRPI0511615B8 true BRPI0511615B8 (pt) 2021-05-25

Family

ID=34980007

Family Applications (1)

Application Number Title Priority Date Filing Date
BRPI0511615A BRPI0511615B8 (pt) 2004-05-28 2005-05-04 forma de administração oral compreendendo bactéria probiótica

Country Status (20)

Country Link
US (2) US20090162322A1 (pt)
EP (1) EP1753440B1 (pt)
JP (1) JP5070043B2 (pt)
KR (1) KR101289413B1 (pt)
CN (1) CN1956724B (pt)
AT (1) ATE386534T1 (pt)
AU (1) AU2005249187B2 (pt)
BR (1) BRPI0511615B8 (pt)
CA (1) CA2568171C (pt)
CY (1) CY1107399T1 (pt)
DE (2) DE102004026706A1 (pt)
DK (1) DK1753440T3 (pt)
ES (1) ES2299034T3 (pt)
MX (1) MXPA06013686A (pt)
PL (1) PL1753440T3 (pt)
PT (1) PT1753440E (pt)
RU (1) RU2376023C2 (pt)
SI (1) SI1753440T1 (pt)
WO (1) WO2005117921A1 (pt)
ZA (1) ZA200610768B (pt)

Families Citing this family (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2368344T3 (es) 2005-05-18 2011-11-16 Dsm Ip Assets B.V. Composiciones para aplicación parenteral de microorganismos.
US9084434B2 (en) * 2006-09-27 2015-07-21 Little Calumet Holdings Llc Probiotic oral dosage forms
KR101485200B1 (ko) * 2006-10-02 2015-01-26 듀폰 뉴트리션 바이오사이언시즈 에이피에스 질병의 발병률 및 지속기간의 감소에 사용하기 위한 프로바이오틱
WO2010114864A1 (en) * 2009-04-01 2010-10-07 Little Calumet Holdings, Llc Probiotic oral dosage forms
EP2464721B1 (en) 2009-08-14 2015-10-21 DuPont Nutrition Biosciences ApS Coated dehydrated microorganisms with enhanced stability and viability
WO2011111783A1 (ja) 2010-03-12 2011-09-15 カルピス株式会社 大腸におけるビフィズス菌の増加及び減少抑制剤
US9585922B2 (en) 2011-05-06 2017-03-07 Organobalance Medical Ag Lactic acid bacteria that co-aggregate with pathogenic bacteria
US9308227B2 (en) 2011-05-16 2016-04-12 Organobalance Medical Ag Lactic acid bacteria and compositions containing them against bacterial colds
ITMI20120131A1 (it) * 2012-02-01 2013-08-02 Probiotical Spa Batteri probiotici microincapsulati multistrato, loro produzione ed uso
WO2013148258A1 (en) 2012-03-29 2013-10-03 Jerome Schentag Gastrointestinal site-specific oral vaccination formulations active on the ileum and appendix
RU2491079C1 (ru) * 2012-07-13 2013-08-27 Федеральное бюджетное учреждение науки Институт элементоорганических соединений им. А.Н. Несмеянова Российской академии наук (ИНЭОС РАН) Комплексный пробиотический препарат и способ его получения
TWI481409B (zh) * 2013-01-10 2015-04-21 Conmed Pharmaceutical & Bio Medical Corp 一種使用益生菌製備用於清除尿毒素之組合物的用途
RU2015140610A (ru) 2013-03-14 2017-04-17 ТЕРАБАЙОМ, ЭлЭлСи Направленная доставка в желудочно-кишечный тракт пробиотических микроорганизмов и/или терапевтических средств
US10849940B2 (en) * 2013-06-10 2020-12-01 Brock M. Lundberg Prebiotics of highly refined cellulose
KR101470995B1 (ko) * 2013-08-30 2014-12-09 주식회사 바이오리쏘스 프로피온산 생산능을 갖는 미생물 및 그를 포함하는 조사료 조성물
JP2017520577A (ja) 2014-07-01 2017-07-27 プロビ ユーエスエー，インコーポレーテッド 二層二放出プロバイオティクス錠剤関連出願の相互参照
ES2575828B1 (es) * 2014-12-31 2017-07-07 Universidad De León Empleo de probióticos en el incremento de la fertilidad masculina
US10339273B2 (en) 2015-11-18 2019-07-02 Warsaw Orthopedic, Inc. Systems and methods for pre-operative procedure determination and outcome predicting
CN111870617B (zh) * 2019-11-04 2022-06-10 深圳碳云智能数字生命健康管理有限公司 肠道益生菌补剂配方的确定方法、装置、存储介质及处理器
CN111110703B (zh) * 2020-01-13 2020-12-01 华中农业大学 动物双歧杆菌及其制备的复合菌制剂在制备治疗或预防禽流感病毒感染的药物中的应用
KR102769334B1 (ko) * 2021-10-20 2025-02-14 경희대학교 산학협력단 대변 미생물총을 포함하는 가축 증체용 조성물
CN114917259B (zh) * 2022-02-15 2023-10-13 中国科学院上海硅酸盐研究所 一种二维氢硅烯-微生物复合材料及其制备方法和应用
TWI857740B (zh) * 2023-08-09 2024-10-01 統一企業股份有限公司 複合益生菌粉及其用途以及益生菌組合物

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS58157726A (ja) * 1982-03-11 1983-09-19 Shin Etsu Chem Co Ltd 固形薬剤用腸溶性コ−テイング剤組成物
JPH024016A (ja) * 1988-06-20 1990-01-09 Fujitsu Ltd 半導体集積回路
JPH0441434A (ja) * 1990-06-07 1992-02-12 Asahi Breweries Ltd 腸溶性コーティングを施した乳酸菌錠剤
US5160742A (en) * 1991-12-31 1992-11-03 Abbott Laboratories System for delivering an active substance for sustained release
IT1265092B1 (it) * 1993-05-31 1996-10-30 Giuliani Spa Preparato per uso come integratore alimentare, o dietetico,a rilascio mirato nel colon
US5482718A (en) * 1994-03-23 1996-01-09 Hoffmann-La Roche Inc. Colon-targeted delivery system
US6168806B1 (en) * 1999-03-05 2001-01-02 Fang-Yu Lee Orally administrable nifedipine pellet and process for the preparation thereof
EP1072258A1 (de) * 1999-07-28 2001-01-31 Greither, Peter Eine Kapsel für die Freisetzung von Bakterien, enthaltend ein Bakterienlyophilisat und ein Verfahren zu ihrer Herstellung
DE19937361A1 (de) * 1999-08-12 2001-02-22 Merck Patent Gmbh Orale Darreichungsform
CN1156271C (zh) * 2000-04-29 2004-07-07 中国科学技术大学 一种固体药剂用高分子包衣粉及其制备方法
US6749867B2 (en) * 2000-11-29 2004-06-15 Joseph R. Robinson Delivery system for omeprazole and its salts
US20020160048A1 (en) * 2001-02-15 2002-10-31 Karoline Bechtold-Peters Medical formulation containing a muscarinic agonist
WO2002071874A2 (en) * 2001-03-09 2002-09-19 Societe Des Produits Nestle S.A. Composition improving age-related physiological deficits and increasing longevity
US7101565B2 (en) * 2002-02-05 2006-09-05 Corpak Medsystems, Inc. Probiotic/prebiotic composition and delivery method
US20040001817A1 (en) * 2002-05-14 2004-01-01 Giampapa Vincent C. Anti-aging nutritional supplement
US20050266069A1 (en) * 2002-09-06 2005-12-01 Simmons Donald L Stable probiotic microsphere compositions and their methods of preparation

Also Published As

Publication number Publication date
CN1956724A (zh) 2007-05-02
RU2376023C2 (ru) 2009-12-20
JP2008500294A (ja) 2008-01-10
ES2299034T3 (es) 2008-05-16
AU2005249187B2 (en) 2011-03-17
CN1956724B (zh) 2013-08-28
KR101289413B1 (ko) 2013-08-07
EP1753440B1 (de) 2008-02-20
CY1107399T1 (el) 2012-12-19
BRPI0511615B1 (pt) 2018-01-23
PT1753440E (pt) 2008-05-28
EP1753440A1 (de) 2007-02-21
ATE386534T1 (de) 2008-03-15
BRPI0511615A (pt) 2008-01-02
DK1753440T3 (da) 2008-06-02
CA2568171C (en) 2013-09-17
CA2568171A1 (en) 2005-12-15
AU2005249187A1 (en) 2005-12-15
JP5070043B2 (ja) 2012-11-07
US20190110997A1 (en) 2019-04-18
DE102004026706A1 (de) 2005-12-15
WO2005117921A1 (de) 2005-12-15
KR20070024539A (ko) 2007-03-02
SI1753440T1 (sl) 2008-08-31
PL1753440T3 (pl) 2008-05-30
US20090162322A1 (en) 2009-06-25
RU2006145056A (ru) 2008-07-10
ZA200610768B (en) 2008-07-30
DE502005002929D1 (de) 2008-04-03
MXPA06013686A (es) 2007-02-13

Similar Documents

Publication Publication Date Title
CY1107399T1 (el) Μορφη χορηγησης απο του στοματος περιεχουσα προβιοτικα βακτηριδια
EP1919302B8 (en) Food comprising silicon
MX2008008321A (es) Metodos para elaborar articulos polimericos y los articulos polimericos formados por este medio.
ATE424159T1 (de) Katheter
ATE407215T1 (de) Enzymatische demethylierung von flavonoiden
MX2007005202A (es) Polisacaridos de estreptococo modificados y usos de los mismos.
RS50832B (sr) Agens oleogela sa sadržajem triterpena, oleogel sa sadržajem triterpena i postupak za proizvodnju oleogela sa sadržajem triterpena
BRPI0817090A2 (pt) Método de cultura e uma espécie bacteriana da família anaplasmataceae, e, composição.
ATE433459T1 (de) Desoxo-nonadepsipeptide
TW200613604A (en) Preparation of fabrics having lotus leaf effect and fabrics having lotus leaf effect
ATE455789T1 (de) Substituierte nonadepsipeptide
FR2907121B1 (fr) Nouveaux derives morphiniques
RU2007145646A (ru) Средство для лечения вич-инфекции
AU316107S (en) Blower pulleys
AU319802S (en) Plenum spacer 1
AU311455S (en) Cycle mudguard
AU308175S (en) Basket
CA117081S (en) Handleset grip
CA115583S (en) Bowl
AU308076S (en) Castor
AU305008S (en) Shelving
CA118016S (en) Slingshot
AU321787S (en) Wardrobe
AU309859S (en) Floorlamp
AU300903S (en) Dining set

Legal Events

Date Code Title Description
B06F Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette]
B07D Technical examination (opinion) related to article 229 of industrial property law [chapter 7.4 patent gazette]
B07E Notification of approval relating to section 229 industrial property law [chapter 7.5 patent gazette]
B15K Others concerning applications: alteration of classification

Ipc: A61K 9/36 (2006.01), A61K 9/28 (2006.01), A61K 35/

B07A Application suspended after technical examination (opinion) [chapter 7.1 patent gazette]
B09A Decision: intention to grant [chapter 9.1 patent gazette]
B16A Patent or certificate of addition of invention granted [chapter 16.1 patent gazette]
B16C Correction of notification of the grant [chapter 16.3 patent gazette]

Free format text: PRAZO DE VALIDADE: 20 (VINTE) ANOS CONTADOS A PARTIR DE 04/05/2005 OBSERVADAS AS CONDICOES LEGAIS. PATENTE CONCEDIDA CONFORME ADI 5.529/DF